EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

The role of fluvoxamine in the treatment of endotoxin‐induced acute heart injury

Ilter Ilhan iD, Halil Aşcı iD, Muhammet Yusuf Tepebasi iD, Nursel Hasseyid iD, Melih Arlıoğlu iD, Özlem Özmen iD

British Journal of Pharmacology · 2026

DOI: 10.1111/bph.70453 ↗

At a glance

Journal article in British Journal of Pharmacology, 2026. Written by Ilter Ilhan and 5 co-authors. Institution: Department of Medical Biochemistry, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey. Major MEDLINE topics: Fluvoxamine, Heart Injuries, Anti-Inflammatory Agents, Selective Serotonin Reuptake Inhibitors. 54 references. The full text is freely available (open access, CC BY 4.0). Funded by: Scientific Research Projects Coordination Unit of Suleyman Demirel University.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Purpose Cardiovascular diseases are among the most common health problems worldwide. Inflammation plays a critical role in the pathogenesis of various heart diseases. Lipopolysaccharides (LPS) trigger inflammatory mechanisms, leading to an inflammatory response. Fluvoxamine (FLV) is a selective serotonin reuptake inhibitor with anti‐inflammatory and antioxidative properties. This study investigated the potential protective effects of FLV on sepsis‐induced cardiac inflammation and injury. Experimental Approach Thirty‐two female Wistar Albino rats were divided into four groups: control, LPS (5 mg·kg −1 intraperitoneally), LPS + FLV, and FLV (50 mg·kg −1 ·day −1 orally for 3 days). Thirty minutes after the final FLV administration, LPS was administered, and animals were killed 6 h later. Cardiac tissues were evaluated by histopathological analysis, immunohistochemical assessment of caspase‐3, TNF‐α, interleukin‐1 beta (IL‐1β), interleukin‐6 receptor (IL‐6R), IL‐10, and NF‐κB; biochemical determination of total oxidant status (TOS), total antioxidant status (TAS), and oxidative stress index (OSI); and gene expression analysis by real‐time quantitative polymerase chain reaction (RT‐qPCR) of sirtuin‐1 (SIRT‐1), nuclear factor erythroid 2–related factor 2 (NRF‐2), peroxisome proliferator‐activated receptor gamma coactivator 1‐alpha (PGC‐1α), and p53. Key Results LPS administration significantly increased TOS, OSI, caspase‐3, TNF‐α, IL‐1β, IL‐6R, NF‐κB, and p53, while decreasing IL‐10, SIRT‐1, NRF‐2, and PGC‐1α, accompanied by marked inflammatory and structural cardiac damage. FLV treatment markedly reversed these alterations, attenuating inflammation, oxidative stress, and apoptosis. Conclusion and Implications These findings suggest that FLV may confer cardioprotection against LPS‐induced inflammatory and apoptotic cardiac injury, potentially through modulation of IL‐6R/NF‐κB‐mediated inflammatory signalling and the SIRT‐1–NRF‐2–PGC‐1α axis.

Subjects

MeSH terms (MEDLINE)

FluvoxamineHeart InjuriesAnti-Inflammatory AgentsSelective Serotonin Reuptake InhibitorsAnimalsFemaleRats, WistarLipopolysaccharidesRatsSirtuin 1Oxidative StressNF-kappa BPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaApoptosisAntioxidantsCytokines

Author keywords

apoptosisfluvoxamineinflammationlipopolysaccharideoxidative stress

Substances

LipopolysaccharidesFluvoxamineSirtuin 1NF-kappa BPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaAnti-Inflammatory AgentsPpargc1a protein, ratAntioxidantsSelective Serotonin Reuptake InhibitorsSirt1 protein, rat

Authors and institutions

  • Department of Medical Biochemistry, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey.
  • Department of Medical Pharmacology, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey.
  • Department of Medical Genetics, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey.
  • Department of Medical Pharmacology, Faculty of Medicine, İstanbul Yeni Yüzyıl University, Istanbul, Turkey.
  • Department of Pathology, Faculty of Veterinary Medicine, Burdur Mehmet Akif Ersoy University, Burdur, Turkey.

ORCID profiles: Ilter Ilhan, Halil Aşcı, Muhammet Yusuf Tepebasi, Nursel Hasseyid, Melih Arlıoğlu, Özlem Özmen

Funding

  • Scientific Research Projects Coordination Unit of Suleyman Demirel University

Cite

APA

Ilhan, I., Aşcı, H., Tepebasi, M. Y., Hasseyid, N., Arlıoğlu, M., & Özmen, Ö. (2026). The role of fluvoxamine in the treatment of endotoxin‐induced acute heart injury. British Journal of Pharmacology. https://doi.org/10.1111/bph.70453

Vancouver

Ilhan I, Aşcı H, Tepebasi MY, Hasseyid N, Arlıoğlu M, Özmen Ö. The role of fluvoxamine in the treatment of endotoxin‐induced acute heart injury. British Journal of Pharmacology. 2026. doi:10.1111/bph.70453

BibTeX
@article{Ilhan2026,
  author = {Ilhan, Ilter and Aşcı, Halil and Tepebasi, Muhammet Yusuf and Hasseyid, Nursel and Arlıoğlu, Melih and Özmen, Özlem},
  title = {The role of fluvoxamine in the treatment of endotoxin‐induced acute heart injury},
  journal = {British Journal of Pharmacology},
  year = {2026},
  doi = {10.1111/bph.70453}
}
Start for free →